You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant BNP

Showing 1 - 25 of 2,614
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Cardiovascular Physiological Phenomena, Metabolism Trial in Nashville (recombinant human BNP (1-32), normal saline ())

Active, not recruiting
  • Obesity
  • +2 more
  • recombinant human BNP (1-32)
  • normal saline (placebo)
  • Nashville, Tennessee
  • +1 more
Mar 23, 2022

Sepsis, Thrombocytopenia Trial in Shanghai (rhTPO, Placebo)

Recruiting
  • Sepsis
  • Thrombocytopenia
  • Shanghai, Shanghai, China
    Shanghai General Hospital, Shanghai Jiaotong University
Oct 25, 2022

Group 3 Pulmonary Hypertension Trial (recombinant human brain natriuretic peptide, Placebo)

Not yet recruiting
  • Group 3 Pulmonary Hypertension
  • recombinant human brain natriuretic peptide
  • Placebo
  • (no location specified)
Jan 30, 2023

Acute Myocardial Infarction Trial in Beijing (Middle Dose, High Dose, Placebo)

Completed
  • Acute Myocardial Infarction
  • Middle Dose
  • +2 more
  • Beijing, China
    Fuwai Hospital, Chinese Academy of Medical Sciences
Jul 31, 2023

Heart Failure With Preserved Ejection Fraction Trial in United States (JK07, Matching Placebo)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Stanford, California
  • +6 more
Jan 30, 2023

Stunting, Wasting, Anemia Trial in Karachi (Benazir Nashonuma Program (BNP))

Recruiting
  • Stunting
  • +3 more
  • Benazir Nashonuma Program (BNP)
  • Karachi, Sindh, Pakistan
    Aga Khan University
Sep 8, 2023

Acute Myocardial Infarction Trial in Beijing (Low Dose, Middle Dose, High Dose)

Completed
  • Acute Myocardial Infarction
  • Low Dose
  • +3 more
  • Beijing, China
    Fuwai Hospital, Chinese Academy of Medical Sciences
Aug 1, 2022

Acute Heart Failure With Chronic Kidney Disease

Recruiting
  • Chronic Kidney Diseases
  • +2 more
    • Taipei, Baitou District, Taiwan
      Cheng Hsin General Hospital
    Aug 17, 2023

    Severe Hemophilia A Trial in China (FRSW117)

    Not yet recruiting
    • Severe Hemophilia A
    • Beijing, China
    • +27 more
    Nov 16, 2023

    Preoperative BNP: Epidemiological Patterns, Management

    Completed
    • Myocardial Infarction Postoperative
    • +2 more
    • Cardiac risk stratification using preoperative BNP measurement, followed by postoperative cardiac monitoring
    • Use of traditional perioperative cardiac risk stratification only
    • Edmonton, Alberta, Canada
      University of Alberta Hospital Pre-Admission Clinic
    Jul 25, 2022

    Low Birthweight, Stunting, Wasting Trial in Dadu (Benazir Nashonuma Program (BNP))

    Recruiting
    • Low Birthweight
    • +5 more
    • Benazir Nashonuma Program (BNP)
    • Dadu, Sindh, Pakistan
      Aga Khan Office
    Apr 28, 2023

    Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)

    Not yet recruiting
    • Bleeding Disorder
    • Recombinant von Willebrand Factor
    • Charlottesville, Virginia
      UVA Hospital
    Nov 3, 2023

    Tooth Extraction, Immediate Implant Placement Trial in Iowa City (Xenogeneic Volume-Stable Collagen (VCMX) graft with growth

    Not yet recruiting
    • Tooth Extraction
    • Immediate Implant Placement
    • Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB
    • Iowa City, Iowa
      University of Iowa College of Dentistry and Dental Clinics
    Sep 8, 2023

    Preoperative BNP and MINS in AAA Open Repair

    Active, not recruiting
    • Myocardial Injury After Non-cardiac Surgery
    • preoperative BNP value
    • Seoul, Korea, Republic of
      Gangnam severance Hospital
    Oct 12, 2023

    Breastfeeding, Exclusive, Pain, Acute, Maternal Distress Trial in Farmington, Hartford (The BSM Intervention, Attention Control)

    Recruiting
    • Breastfeeding, Exclusive
    • +4 more
    • The BSM Intervention
    • Attention Control
    • Farmington, Connecticut
    • +1 more
    Jun 15, 2022

    Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

    Enrolling by invitation
    • Malignant Melanomas
    • Recombinant Human Adenovirus Type 5 Injection
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
    Jul 7, 2023

    Hemophilia A Trial (Nuwiq)

    Not yet recruiting
    • Hemophilia A
    • (no location specified)
    Jul 3, 2023

    Pulmonary Arterial Hypertension Participants Treated With

    Recruiting
    • Pulmonary Arterial Hypertension
    • PAH medication
    • Acquaviva Delle Fonti, Italy
    • +34 more
    Feb 1, 2023

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Radiotherapy
    • +4 more
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Sep 14, 2023

    Severe Hemophilia A Trial (Nuwiq)

    Not yet recruiting
    • Severe Hemophilia A
    • (no location specified)
    Jul 3, 2023

    Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

    Not yet recruiting
    • Salivary Gland Cancer
    • vedicitumomab (Edisil, RC48）
    • +3 more
    • (no location specified)
    Jun 9, 2023

    Repeatability of NT-proBNP Testing Using Laboratory and Point of

    Active, not recruiting
    • Pulmonary Artery Hypertension
    • Exercise group
    • Sheffield, South Yorkshire, United Kingdom
      Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital
    Jun 14, 2022

    Health, Subjective Trial in Seoul (BMI2004, 0.9% NaCl)

    Completed
    • Health, Subjective
    • BMI2004
    • 0.9% NaCl
    • Seoul, Heukseok-ro, Dongjak-gu, Korea, Republic of
      Chung-Ang University Hospital
    Jun 26, 2023

    COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

    Recruiting
    • COVID-19
    • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
    • Guangzhou, Guangzhou, China
      The Fifth Affiliated Hospital of Guangzhou Medical University
    Jan 28, 2023

    COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

    Recruiting
    • COVID-19
    • Recombinant new coronavirus vaccine (CHO cell)
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Jun 2, 2023